SCHEMBL24470385

SCHEMBL24470385

O=P(c1ccc(-c2cccc3ccccc23)cc1)(c1ccc2ccc3cccnc3c2n1)c1ccc2ccc3cccnc3c2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
MAPT P10636 3/20 0.40
LMNA P02545 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP3A4 P08684 2/20 0.40
CCR1 P32246 2/20 0.40
CCR5 P51681 2/20 0.40
CCR8 P51685 2/20 0.40
GMNN O75496 1/20 0.40
TP53 P04637 1/20 0.40
HSP90AA1 P07900 1/20 0.40
MMP2 P08253 1/20 0.40
CYP2D6 P10635 1/20 0.40
MMP9 P14780 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
MMP8 P22894 1/20 0.40
THPO P40225 1/20 0.40
MTOR P42345 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18372153 0.84 CCR1 (0.39) KDM4EMAPTLMNASMN1; SMN2CYP3A4
SCHEMBL20108841 0.83 CCR1 (0.46) KDM4EMAPTLMNASMN1; SMN2CYP3A4
SCHEMBL11990948 0.82 LMNA (0.52) KDM4EMAPTLMNASMN1; SMN2CYP3A4
SCHEMBL18372028 0.81 MAPT (0.43) KDM4EMAPTLMNASMN1; SMN2CYP3A4
SCHEMBL20108847 0.80 LMNA (0.52) KDM4EMAPTLMNASMN1; SMN2CYP3A4
SCHEMBL9927240 0.78 CA12 (0.57) HDAC8HDAC6CA12CA1CA2
SCHEMBL17451947 0.78 TOP1 (0.44) KDM4EMAPTLMNASMN1; SMN2CYP3A4
SCHEMBL20108867 0.78 LMNA (0.40) KDM4EMAPTLMNASMN1; SMN2CYP3A4
SCHEMBL17451986 0.77 ENPP1 (0.47) KDM4EMAPTLMNASMN1; SMN2CYP3A4
SCHEMBL11962384 0.77 KDM4E (0.43) KDM4EMAPTLMNASMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230284524-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-07 US disclosed
US-20220190296-A1 LIGHT-EMITTING DEVICE AND AN ELECTRONIC DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-06-16 US disclosed
US-20220173331-A1 LIGHT-EMITTING DEVICE AND AN ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230284524-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME EML4, SLC1A2, EMD KDM4E 1756/4885MAPT 2628/4885LMNA 2421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.